Stuart Rich's most recent trade in Tenax Therapeutics Inc was a trade of 625,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 16, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tenax Therapeutics Inc | Stuart Rich | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2025 | 625,000 | 625,000 | - | - | Stock Option (right to buy) | |
| Tenax Therapeutics Inc | Rich Stuart | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 500,000 | 500,000 | - | - | Stock Option (right to buy) | |
| Tenax Therapeutics Inc | Stuart Rich | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 119 | 119 | - | - | Stock Option (right to buy) | |
| Tenax Therapeutics Inc | Stuart Rich | Director, Chief Medical Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Oct 2021 | 1,909,585 | 1,909,585 (28%) | 28% | 0 | Common Stock | |
| Tenax Therapeutics Inc | Stuart Rich | Director, Chief Medical Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Oct 2021 | 1,909,585 | 0 (0%) | 28% | 0 | Common stock | |
| Tenax Therapeutics Inc | Stuart Rich | Director, Chief Medical Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Oct 2021 | 1,909,585 | 1,909,585 (28%) | 28% | 0 | Common stock | |
| Tenax Therapeutics Inc | Stuart Rich | Director, Chief Medical Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Oct 2021 | 1,909,585 | 2,333,932 (34%) | 28% | 0 | Common Stock | |
| Tenax Therapeutics Inc | Stuart Rich | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 662,517 | 662,517 (9%) | 9% | - | Common Stock | |
| Tenax Therapeutics Inc | Stuart Rich | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 250,000 | 250,000 | - | - | Stock Option (right to buy) | |
| Tenax Therapeutics Inc | Stuart Rich | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 3,581 | 3,581 | - | - | Series B Preferred Stock |